Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Citizens, Inc. (CIA:NYSE), powered by AI.
Citizens, Inc. is currently trading at $5.56. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Citizens, Inc. on Alpha Lenz.
Citizens, Inc.'s P/E ratio is 19.1.
“Citizens, Inc. trades at a P/E of 19.1 (fair value) with modest ROE of 6.6%.”
Ask for details →Citizens, Inc. is an insurance holding company that primarily provides life insurance to individuals across international markets. The company's primary function is to offer a variety of insurance products, including ordinary whole life policies, endowment policies, and credit life insurance. These products are designed to provide death benefits, cash value accumulation, and life coverage to policyholders, emphasizing long-term security and financial planning. Citizens, Inc. operates in diverse geographic regions, focusing on Latin America and the United States, thereby playing a crucial role in the life insurance sector within these markets. Through its subsidiaries, the company has established a significant presence in serving niche markets, offering tailored insurance solutions that meet local regulatory and customer needs. In the financial market, Citizens, Inc. contributes to the insurance segment, influencing investment and underwriting practices within its operational territories. The company's adaptive strategies and focus on growing markets underscore its importance in expanding life insurance accessibility and ensuring financial protection for various communities. Founded in 1969 and headquartered in Austin, Texas, Citizens, Inc. continues to evolve in response to demographic and economic shifts.
“Citizens, Inc. trades at a P/E of 19.1 (fair value) with modest ROE of 6.6%.”
Ask for details →Citizens, Inc. (ticker: CIA) is a company listed on NYSE in the Financial Services sector (Insurance - Life). It has approximately 247 employees. Market cap is $279M.
The current price is $5.56 with a P/E ratio of 19.11x and P/B of 1.19x.
ROE is 6.55%. Annual revenue is $256M.